» Articles » PMID: 28272344

Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection

Abstract

Pancreatic cancer is an aggressive malignancy with a poor prognosis. The disease and its treatment can cause significant nutritional impairments that often adversely impact patient quality of life (QOL). The pancreas has both exocrine and endocrine functions and, in the setting of cancer, both systems may be affected. Pancreatic exocrine insufficiency (PEI) manifests as weight loss and steatorrhea, while endocrine insufficiency may result in diabetes mellitus. Surgical resection, a central component of pancreatic cancer treatment, may induce or exacerbate these dysfunctions. Nutritional and metabolic dysfunctions in patients with pancreatic cancer lack characterization, and few guidelines exist for nutritional support in patients after surgical resection. We reviewed publications from the past two decades (1995-2016) addressing the nutritional and metabolic status of patients with pancreatic cancer, grouping them into status at the time of diagnosis, status at the time of resection, and status of nutritional support throughout the diagnosis and treatment of pancreatic cancer. Here, we summarize the results of these investigations and evaluate the effectiveness of various types of nutritional support in patients after pancreatectomy for pancreatic adenocarcinoma (PDAC). We outline the following conservative perioperative strategies to optimize patient outcomes and guide the care of these patients: (1) patients with albumin < 2.5 mg/dL or weight loss > 10% should postpone surgery and begin aggressive nutrition supplementation; (2) patients with albumin < 3 mg/dL or weight loss between 5% and 10% should have nutrition supplementation prior to surgery; (3) enteral nutrition (EN) should be preferred as a nutritional intervention over total parenteral nutrition (TPN) postoperatively; and, (4) a multidisciplinary approach should be used to allow for early detection of symptoms of endocrine and exocrine pancreatic insufficiency alongside implementation of appropriate treatment to improve the patient's quality of life.

Citing Articles

Effect of travel distance on utilization of ancillary services among patients with pancreatic ductal adenocarcinoma: A single institution study.

Myneni R, Pathak P, Hacker-Prietz A, He J, Kumar R, Narang A Support Care Cancer. 2025; 33(4):282.

PMID: 40088289 DOI: 10.1007/s00520-025-09339-3.


Preoperative levels of physical activity can be increased in pancreatectomy patients via a remotely monitored, telephone-based intervention: A randomized trial.

Rodriguez J, Cos H, Srivastava R, Bewley A, Raper L, Li D Surg Pract Sci. 2025; 15:100212.

PMID: 39844811 PMC: 11749940. DOI: 10.1016/j.sipas.2023.100212.


A novel model based on clinical and computed tomography (CT) indices to predict the risk factors of postoperative major complications in patients undergoing pancreaticoduodenectomy.

Wang J, Xu K, Zhou C, Wang X, Zuo J, Zeng C PeerJ. 2024; 12:e18753.

PMID: 39713149 PMC: 11663404. DOI: 10.7717/peerj.18753.


Omega-3 Supplementation and Nutritional Status in Patients with Pancreatic Neoplasms: A Systematic Review.

Pires L, Salaroli L, Podesta O, Kenji Haraguchi F, Lopes-Junior L Nutrients. 2024; 16(23).

PMID: 39683430 PMC: 11643750. DOI: 10.3390/nu16234036.


Therapeutic potential of β-hydroxybutyrate in the management of pancreatic neoplasms: exploring novel diagnostic and treatment strategies.

Vaezi M, Nekoufar S, Robati A, Salimi V, Tavakoli-Yaraki M Lipids Health Dis. 2024; 23(1):376.

PMID: 39543582 PMC: 11562866. DOI: 10.1186/s12944-024-02368-7.


References
1.
Augustin T, Burstein M, Schneider E, Morris-Stiff G, Wey J, Chalikonda S . Frailty predicts risk of life-threatening complications and mortality after pancreatic resections. Surgery. 2016; 160(4):987-996. DOI: 10.1016/j.surg.2016.07.010. View

2.
Barber M, Fearon K, Tisdale M, McMillan D, Ross J . Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer. 2002; 40(2):118-24. DOI: 10.1207/S15327914NC402_7. View

3.
Richter E, Denecke A, Klapdor S, Klapdor R . Parenteral nutrition support for patients with pancreatic cancer--improvement of the nutritional status and the therapeutic outcome. Anticancer Res. 2012; 32(5):2111-8. View

4.
Bye A, Jordhoy M, Skjegstad G, Ledsaak O, Iversen P, Hjermstad M . Symptoms in advanced pancreatic cancer are of importance for energy intake. Support Care Cancer. 2012; 21(1):219-27. DOI: 10.1007/s00520-012-1514-8. View

5.
Park J, Chung H, Hwang H, Kim J, Yoon D . Postoperative nutritional effects of early enteral feeding compared with total parental nutrition in pancreaticoduodectomy patients: a prosepective, randomized study. J Korean Med Sci. 2012; 27(3):261-7. PMC: 3286772. DOI: 10.3346/jkms.2012.27.3.261. View